$42.57
4.34%
NYSE, Nov 16, 04:19 pm EST. Closed.
ISIN
US8816242098
Symbol
TEVA

Teva Pharmaceutical Industries Limited Sponsored ADR Stock News

Neutral
●
GlobeNewsWire
●
6 days ago
Teva hosts its first R&D Day, sharing pipeline updates and a target of $6–7 billion in innovative medicines revenue by 2030 as a high-velocity biopharma.
Positive
●
Reuters
●
14 days ago
Teva Pharmaceutical Industries expects to grow in ​2027 despite the US ‌inflation reduction act that will cap prices for its top ​branded drug Austedo to ​treat Huntington's Disease and Tardive ⁠Dyskinesia, CEO Richard Francis ​said on Tuesday.
Positive
●
Investors Business Daily
●
14 days ago
Teva stock advanced early Tuesday on better-than-expected third-quarter metrics and a raised outlook for 2026.
Positive
●
Reuters
●
14 days ago
Israeli drugmaker Teva Pharmaceutical Industries, reported on Tuesday ​a higher-than-expected rise in third-quarter ‌profit, helped by strong sales of a trio of its own ​drugs to offset declines in ​copycat medicines.
Neutral
●
GlobeNewsWire
●
14 days ago
Teva to obtain U.S. commercialization rights for two immunology biosimilars: ETICOVO® upon close and infliximab-abda in Q3 2027 Collaboration combines Samsung Bioepis' biosimilar expertise with Teva's commercial capabilities Agreement expands collaboration with Samsung Bioepis, strengthening Teva's generics powerhouse and biosimilars portfolio as part of its Pivot to Growth strategy TEL AVIV, I...
Negative
●
Reuters
●
15 days ago
Teva said ​on Monday it was discontinuing its mid-stage neurodegenerative disorder ‌study due to a low probability of the study meeting its main goal if continued.
Neutral
●
GlobeNewsWire
●
21 days ago
Teva acquires worldwide rights to BXCL501, expanding its neuroscience pipeline with a potential at-home treatment for agitation currently under FDA review

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today